| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,581 |
8,045 |
$296K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,649 |
8,084 |
$279K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,268 |
7,515 |
$57K |
| 80053 |
Comprehensive metabolic panel |
6,667 |
6,081 |
$56K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,176 |
1,076 |
$53K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
770 |
642 |
$43K |
| 87631 |
|
592 |
544 |
$37K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,136 |
2,674 |
$26K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
560 |
438 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,518 |
1,231 |
$18K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
472 |
441 |
$10K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
556 |
139 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
905 |
845 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
503 |
482 |
$7K |
| 80306 |
|
620 |
572 |
$7K |
| 84484 |
|
1,090 |
839 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
1,129 |
1,047 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
92 |
89 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
143 |
137 |
$4K |
| 81000 |
|
1,486 |
1,368 |
$4K |
| 97032 |
|
409 |
108 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
277 |
177 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
386 |
355 |
$4K |
| 82553 |
|
391 |
306 |
$3K |
| 87070 |
|
293 |
283 |
$3K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
134 |
122 |
$3K |
| 83874 |
|
394 |
309 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
103 |
94 |
$2K |
| 83690 |
|
338 |
315 |
$2K |
| 82550 |
|
430 |
336 |
$2K |
| 86762 |
|
88 |
80 |
$2K |
| 81025 |
|
517 |
488 |
$2K |
| 99001 |
|
461 |
443 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
13 |
12 |
$1K |
| 70450 |
Computed tomography, head or brain; without contrast material |
26 |
24 |
$1K |
| 83880 |
|
70 |
66 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
140 |
121 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
53 |
48 |
$918.69 |
| 87340 |
|
67 |
62 |
$858.46 |
| 84443 |
Thyroid stimulating hormone (TSH) |
51 |
48 |
$799.37 |
| 80305 |
|
129 |
118 |
$795.72 |
| 0011A |
|
18 |
18 |
$720.00 |
| 80061 |
Lipid panel |
43 |
43 |
$698.00 |
| 0012A |
|
17 |
17 |
$680.00 |
| 81003 |
|
285 |
262 |
$607.61 |
| 86850 |
|
90 |
81 |
$528.75 |
| 86592 |
|
104 |
95 |
$523.13 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
687 |
632 |
$471.51 |
| 82677 |
|
14 |
14 |
$421.40 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$365.64 |
| 84702 |
|
27 |
26 |
$347.06 |
| 82105 |
|
14 |
14 |
$308.14 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14 |
14 |
$299.16 |
| 87150 |
|
12 |
12 |
$284.24 |
| 86336 |
|
14 |
14 |
$267.40 |
| 86900 |
|
89 |
81 |
$243.46 |
| 86901 |
|
89 |
81 |
$241.24 |
| 87899 |
|
24 |
14 |
$220.22 |
| 82150 |
|
39 |
38 |
$217.89 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
589 |
545 |
$217.65 |
| 87335 |
|
15 |
14 |
$216.82 |
| 87045 |
|
15 |
14 |
$178.92 |
| 83630 |
|
14 |
13 |
$160.55 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$155.54 |
| 85610 |
|
66 |
58 |
$154.31 |
| 86706 |
|
15 |
13 |
$145.50 |
| 85027 |
|
46 |
30 |
$128.60 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
95 |
89 |
$125.90 |
| 87040 |
|
20 |
13 |
$121.32 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12 |
12 |
$98.78 |
| 80076 |
|
12 |
12 |
$91.96 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
196 |
178 |
$83.75 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
14 |
$66.48 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,052 |
1,897 |
$58.55 |
| 85730 |
|
43 |
38 |
$43.80 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
567 |
532 |
$42.46 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
434 |
378 |
$42.36 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
16 |
13 |
$27.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
25 |
12 |
$22.61 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
188 |
182 |
$18.44 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
217 |
201 |
$12.81 |
| 36415 |
Collection of venous blood by venipuncture |
1,108 |
1,033 |
$8.12 |
| A0425 |
Ground mileage, per statute mile |
3,606 |
2,908 |
$0.00 |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
545 |
482 |
$0.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
16 |
13 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
28 |
25 |
$0.00 |
| 31000 |
|
100 |
49 |
$0.00 |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
1,772 |
1,576 |
$0.00 |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
768 |
515 |
$0.00 |